European Archives - Page 114 of 1447 - European Medical Journal

Nivolumab Outcomes Linked to Immune Blood Markers - EMJ

Blood-Based Immune Markers May Predict Outcomes in Kidney Cancer Treated with Nivolumab

Baseline eosinophil levels and early blood count changes may help predict survival and response in metastatic renal cell carcinoma patients treated with nivolumab.

Ants Could Inspire the Next Generation of Antibiotics

Ants produce diverse, targeted antimicrobial compounds that inhibit drug-resistant pathogens, including Candida auris, offering insights for new antibiotics.

ovarian cancer

New Tool Predicts Ovarian Surgery Success

Researchers have developed a new prediction tool that could help clinicians better assess whether complete tumour removal is achievable in women with advanced epithelial ovarian cancer.

Decoding the Genetics of Long COVID

A multi-omics study identifies causal genes and biological subtypes of Long COVID, revealing new therapeutic targets for personalised care.

Rare Genetic Variants Shed Light on Familial Lung Cancer Risk

Rare inherited genetic variants linked to mucin glycosylation and DNA repair significantly increase familial lung cancer risk, offering new targets for early detection.

Sarcoidosis

Novel Sarcoidosis PET/CT Tracer Highlights Systemic Inflammation

A proof-of-concept trial shows novel sarcoidosis PET/CT tracer detects inflammatory activity, supporting further clinical evaluation.

Intermittent Fasting or Calorie Restriction for Heart Health?

New real-world data suggest 5:2 intermittent fasting may offer modest cardiovascular benefits over calorie restriction in adults with overweight or obesity.

Male Infertility

Diabetes Linked to Male Infertility via Inflammation

Meta-analysis shows diabetes increases male infertility risk, with inflammation identified as a key underlying mechanism.

Autumn Clock Change and Short-term Health Effects - EMJ

Autumn Clock Change Linked to Reduced Mental and Cardiovascular Health Events

A large study found fewer mental health and cardiovascular events following the autumn daylight saving time clock change in England.

Hepatitis B

Rethinking Endpoints in Chronic Hepatitis B Treatment

By broadening definition of success to include sustained low-level HBsAg with suppressed HBV DNA, we can recognize clinically meaningful responses that improve patient outcomes, even without full antigen clearance.